BDX · Becton Dickinson & Co
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-07-02 | Muhsin Bilal |
Chief Operating Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. |
Common Stock
|
1,935 |
| 2026-07-01 | Muhsin Bilal |
Chief Operating Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
Common Stock
|
14,342 |
| 2026-06-26 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
|
Common Stock
|
75 |
| 2026-06-24 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Sell↓
|
Common Stock
|
1,100 |
| 2026-06-10 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Sell↓
Filing footnotes — Common Stock (Direct)
Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
Common Stock
|
1,100 |
| 2026-06-01 | Polen Thomas E Jr |
Chairman, CEO and President |
Sell↓
Filing footnotes — Common Stock (Direct)
The reported sale price reflects the weighted average sale price for multiple transactions. The actual sales prices for the transactions ranged from $145.21 through $147.49. Full information regarding the number of shares purchased at each separate price will be provided to the Securities and Exchange Commission, the issuer or a security holder of the issuer upon request. Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
Common Stock
|
2,764 |
| 2026-06-01 | Polen Thomas E Jr |
Chairman, CEO and President |
Convert↑
|
Common Stock
|
20,209 |
| 2026-06-01 | Polen Thomas E Jr |
Chairman, CEO and President |
Convert↓
Filing footnotes — Stock Appreciation Rights (Direct)
Award terms reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. The stock appreciation rights vested in four annual installments beginning November 26, 2017. |
Stock Appreciation Rights
|
20,209 |
| 2026-06-01 | Menziuso Peter |
EVP and President, BDI |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
Common Stock
|
14,258 |
| 2026-06-01 | Polen Thomas E Jr |
Chairman, CEO and President |
Other↓
|
Common Stock
|
17,445 |
| 2026-05-26 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
|
Common Stock
|
75 |
| 2026-05-08 | Byington Carrie L |
Director |
Award↑
Filing footnotes — Rights to Common Stock Under BD Deferred Compensation Plan (Direct)
The securities convert to common stock on a one-for-one basis. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person. |
Rights to Common Stock Under BD Deferred Compensation Plan
|
105 |
| 2026-05-08 | Huffines Robert Luther |
Director |
Award↑
Filing footnotes — Rights to Common Stock Under BD Deferred Compensation Plan (Direct)
The securities convert to common stock on a one-for-one basis. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. Includes rights acquired through dividend investment since the last report filed by the reporting person. Reflects the adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of previously reported derivative securities held by the reporting person. |
Rights to Common Stock Under BD Deferred Compensation Plan
|
210 |
| 2026-05-07 | Roque Vitor |
Interim CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
Common Stock
|
1,721 |
| 2026-04-27 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
|
Common Stock
|
74 |
| 2026-04-06 | Neal Shana Carol |
Chief Human Resources Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
Common Stock
|
1,146 |
| 2026-03-26 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
This reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 7, 2025. |
Common Stock
|
75 |
| 2026-03-16 | Minnix Lanesha |
EVP, GC & SECRETARY |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
Common Stock
|
7,492 |
| 2026-03-02 | Spikner Pamela L. |
SVP Controller & CAO |
Award↑
Filing footnotes — Common Stock (Direct)
Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
Common Stock
|
931 |
| 2026-03-02 | Roque Vitor |
Interim CFO |
Award↑
Filing footnotes — Common Stock (Direct)
Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
Common Stock
|
931 |
| 2026-02-26 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
Filing footnotes — Common Stock (Direct)
Direct holdings reflect adjustments made in connection with the combination of the Biosciences and Diagnostic Solutions businesses with Waters Corp. to the number of shares underlying previously reported and unvested time-vested restricted stock units held by the reporting person. |
Common Stock
|
75 |
| 2026-02-18 | SCOTT BERTRAM L |
Director |
Sell↓
|
Common Stock
|
953 |
| 2026-02-04 | Jones Christopher Ian Montague |
Director |
Award↑
Filing footnotes — Rights to Common Stock Under BD Deferred Compensation Plan (Direct)
The securities convert to common stock on a one-for-one basis. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. |
Rights to Common Stock Under BD Deferred Compensation Plan
|
272 |
| 2026-02-04 | Huffines Robert Luther |
Director |
Award↑
Filing footnotes — Rights to Common Stock Under BD Deferred Compensation Plan (Direct)
The securities convert to common stock on a one-for-one basis. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. |
Rights to Common Stock Under BD Deferred Compensation Plan
|
100 |
| 2026-02-04 | Byington Carrie L |
Director |
Award↑
Filing footnotes — Rights to Common Stock Under BD Deferred Compensation Plan (Direct)
The securities convert to common stock on a one-for-one basis. The securities are distributed following termination of the reporting person's service as a director, or on the date or dates specified by the reporting person. Includes rights acquired through dividend reinvestment since the last report filed by the reporting person. |
Rights to Common Stock Under BD Deferred Compensation Plan
|
30 |
| 2026-01-27 | Byington Carrie L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | Waldstreicher Joanne |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | HAYES GREGORY |
Director, Executive Chairman |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | Wright Jacqueline |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | Henderson Jeffrey William |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | Jones Christopher Ian Montague |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | SCOTT BERTRAM L |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | Brown William M |
Chairman & CEO |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | Huffines Robert Luther |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | RING TIMOTHY M |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-27 | ECKERT R ANDREW |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. Includes units acquired through dividend investment since the last report filed by the reporting person. |
Common Stock
|
1,098 |
| 2026-01-26 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
|
Common Stock
|
75 |
| 2026-01-21 | Spikner Pamela L. |
SVP Controller & CAO |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld for payment of withholding taxes in connection with the vesting of restricted stock units previously reported on Table I. |
Common Stock
|
84 |
| 2026-01-15 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Other↓
|
Common Stock
|
2,454 |
| 2026-01-15 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Convert↓
Filing footnotes — Stock Appreciation Rights (Direct)
The stock appreciation rights vested in four annual installments beginning one year from the grant date. |
Stock Appreciation Rights
|
3,054 |
| 2026-01-15 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Sell↓
|
Common Stock
|
600 |
| 2026-01-15 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Convert↑
|
Common Stock
|
3,054 |
| 2026-01-15 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Sell↓
|
Common Stock
|
1,010 |
| 2026-01-03 | Shan David |
EVP and Chief ISC Officer |
Tax↓
Filing footnotes — Common Stock (Direct)
Represents shares withheld for payment of withholding taxes in connection with vesting of previously reported restricted stock unit awards. |
Common Stock
|
44 |
| 2025-12-26 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
|
Common Stock
|
74 |
| 2025-12-17 | Garrison Michael David |
EVP & Pres Med.Essntl&BioPharm |
Sell↓
|
Common Stock
|
629 |
| 2025-12-01 | Feld Michael |
EVP, Chief Revenue Officer |
Sell↓
|
Common Stock
|
75 |
| 2025-12-01 | Huffines Robert Luther |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
Common Stock
|
180 |
| 2025-12-01 | Wright Jacqueline |
Director |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
Common Stock
|
180 |
| 2025-11-26 | Neal Shana Carol |
Chief Human Resources Officer |
Award↑
Filing footnotes — Common Stock (Direct)
Represents restricted stock units awarded under the Becton, Dickinson and Company 2004 Employee and Director Equity-Based Compensation Plan. |
Common Stock
|
6,727 |